A novel Selective BCL2 inhibitor with limited immune suppression and improved safety compared to venetoclax

Dec 19

Written By Guest User

Download Poster

Guest User

Therapeutic Targeting of FLT3 gate keeper mutation with E2082-0047 in traditional and a novel Immunocompetent murine adoptive transfer model of AML